These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21975154)

  • 1. Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.
    Ustrup M; Madsen LB; Bygbjerg IC; Konradsen F
    Dan Med Bull; 2011 Oct; 58(10):A4323. PubMed ID: 21975154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.
    Tate JE; Burton AH; Boschi-Pinto C; Steele AD; Duque J; Parashar UD;
    Lancet Infect Dis; 2012 Feb; 12(2):136-41. PubMed ID: 22030330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
    Patel MM; Glass R; Desai R; Tate JE; Parashar UD
    Lancet Infect Dis; 2012 Jul; 12(7):561-70. PubMed ID: 22742639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of rotavirus vaccination programs in developing countries.
    Hallowell BD; Tate J; Parashar U
    Expert Rev Vaccines; 2020 Jun; 19(6):529-537. PubMed ID: 32543239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy.
    Lopez AL; Raguindin PF; Silva MWT
    Hum Vaccin Immunother; 2019; 15(6):1260-1264. PubMed ID: 30513238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccination in developing countries.
    Babji S; Kang G
    Curr Opin Virol; 2012 Aug; 2(4):443-8. PubMed ID: 22698800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vaccine on rotavirus disease in the pediatric population.
    Dennehy PH
    Curr Opin Pediatr; 2012 Feb; 24(1):76-84. PubMed ID: 22189398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of immunisation against rotavirus.
    Marlow RD; Finn A
    Arch Dis Child; 2012 Aug; 97(8):736-40. PubMed ID: 22611059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of rotavirus vaccines in developing countries: remaining challenges.
    Cunliffe N; Nakagomi O
    Ann Trop Paediatr; 2007 Sep; 27(3):157-67. PubMed ID: 17716443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccines: current prospects and future challenges.
    Glass RI; Parashar UD; Bresee JS; Turcios R; Fischer TK; Widdowson MA; Jiang B; Gentsch JR
    Lancet; 2006 Jul; 368(9532):323-32. PubMed ID: 16860702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.
    Shah MP; Tate JE; Mwenda JM; Steele AD; Parashar UD
    Expert Rev Vaccines; 2017 Oct; 16(10):987-995. PubMed ID: 28832219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccine for preventing diarrhoea.
    Soares-Weiser K; Goldberg E; Tamimi G; Pitan OC; Leibovici L
    Cochrane Database Syst Rev; 2004; 2004(1):CD002848. PubMed ID: 14973994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease.
    Glass RI; Tate JE; Jiang B; Parashar U
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S331-S342. PubMed ID: 34590142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.